The industrial company Ziacom Medical, founded in 2004, has given Suma Capital a 40% stake in its shareholding, with the aim of supporting an ambitious expansion plan. Its founder and manager, Alejandro del Valle, will maintain the majority stake and will lead the growth of the business from its headquarters in Pinto, Madrid.
The company is currently one of the leading manufacturers of medical technology for the dental sector in Spain, specialising in the design, manufacture and marketing of dental implants and attachments, biomaterials and surgical instruments.
Ziacom stands out for its extensive catalogue of products, which has earned it the trust of a broad and balanced portfolio of customers, efficiently supplying both small and large dental clinics. The group also has its own centre specialising in digital CAD-CAM technology.
The company, which has been growing annually at a rate of over 15%, exceeded 11 million euros in turnover in 2021, with more than 1,000 customers and an international presence in 17 countries, including the US market where Ziacom has its own headquarters and FDA approval.
With the support of Suma Capital, Ziacom’s growth strategy will focus on three basic pillars: increasing penetration in Spain, extending its leadership to other markets, mainly in Southern Europe, and launching new product families and services to build loyalty among current and future customers.
To this end, it intends to make significant investments in R&D, as well as recruit new talent and strengthen the sales network. The company does not rule out the acquisition of complementary companies, both nationally and internationally, provided that this allows it to accelerate the achievement of these objectives.
Suma Capital has been advised on the analysis of this investment by C&S, Pwc Strategy, Grant Thornton, Fourlaw, and ESG specialist Attalea Partners. On legal matters, Suma Capital has been advised by Bufete Castilla, while the founder of Ziacom has been advised by Ortego & Cameno Abogados.
CEO and founder Alejandro del Valle stated that “we believe that Suma Capital is the support partner we need in this phase of international growth that we are accelerating, helping us to prioritise those strategic issues that currently occupy the company”.
“Ziacom’s ambition and growth potential is undoubtedly something that attracted us from day one. We are convinced that our partnership and commitment will help the company continue to grow in an orderly, solid and profitable manner,” said Manuel Cebrián, Investment Director of Suma Capital.
Ortego & Cameno Abogados advised the seller with a team led by Corporate and M&A partner Luis Ortego Castañeda, and supported by lawyers Manuel Herrero Rodríguez and José Gollonet Bautista.
Grant Thornton´steam advising Suma Capital on the deal Financial matters was led by Financial Advisory partner Eduard Gellida, manager Marina Rullan, and consultant Gerard Massó.